IMNM
Immunome
$18.76
−$0.01 (−0.05%)Oct 28, 2026
Key metrics
The numbers that frame IMNM today
- Market cap
- $2.13B
- ROIC
- -320.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $14.64
- 52wk High
- $30.06
Growth
Revenue and earnings trend for IMNM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IMNM
Is Immunome a good buy?
No. Immunome has strong momentum, but poor quality undercuts the setup. Growth looks weak. That could put pressure on the long-term business case. We think Immunome is selling at a very high price.
What is the market capitalization of IMNM?
Immunome's market capitalization is $2.13B.
What is the 52-week high for IMNM stock?
The 52-week high for Immunome is $30.06. The current close of $18.76 is 37.6% below that high.
What is the 52-week low for IMNM stock?
The 52-week low for Immunome is $14.64. The current close of $18.76 is 28.1% above that low.
Does IMNM stock pay dividends?
Immunome does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IMNM?
Immunome's Debt / Equity ratio is 0.01.